RedefiningPrecisionDiagnostics
First-to-market certified AI solutions transforming cancer and kidney disease diagnostics across Europe
2021
Founded
11-50
Team Members
$6.4M
Total Funding
60%
Time Saved
Why Aiosyn
Three pillars that make us the leader in AI pathology diagnostics
CE-IVDR Certified
Clinical-grade AI with regulatory approval for European diagnostics.
Instant Integration
Plug-and-play compatibility with existing pathology workflows.
Research Excellence
Built on 20+ years of academic research from Radboudumc.
Our Products
Three innovative solutions addressing critical needs in pathology diagnostics
Aiosyn Mitosis Breast
World's first certified AI for mitosis detection in breast cancer diagnostics
AiosynQC
Automated pre-scan quality control detecting artifacts before imaging
NephroPath Platform
Edge AI platform for advanced kidney pathology research
Transform Your
Diagnostic Workflow
Join leading pathology labs across Europe in revolutionizing cancer diagnostics with AI